每年出版 3 期
ISSN 打印: 0892-0915
ISSN 在线: 2375-0014
Cannabinoid/Opioid Crosstalk in the Central Nervous System
摘要
Promising therapeutic uses and a great variety of pharmacological effects are the leading forces that focus actual cannabinoid research. Cannabinoid and opioid systems share neuroanatomical, neurochemical, and paharmacological features. This fact supports the notion that actions induced by each one of these types of drugs involved an interaction between the endogenous opioid and endocannabinoid neuronal systems. Over the last decade our group and others have investigated cannabinoid/opioid crosstalk in the central nervous system by studying the mechanisms underlying pharmacological and biochemical interactions between the two systems in experimental paradigms of antinociception, drug reinforcement, and anxiety. The goal of this review is to revise the latest work done on this subject, with special emphasis on the research done with genetically modified animals. Whereas clinical progress is going ahead slowly, basic research in this area is progressing rapidly. Clinical applications derived from the cannabinoid/opioid crosstalk and based tightly on medical evidence are yet to come, but it is hoped that knowledge of this central messenger interaction will help to develop new alternatives for the treatment of some pathological states.
-
Capasso R, Borrelli F, Cascio M G, Aviello G, Huben K, Zjawiony J K, Marini P, Romano B, Di Marzo V, Capasso F, Izzo A A, Inhibitory effect of salvinorin A, from Salvia divinorum , on ileitis-induced hypermotility: cross-talk between κ-opioid and cannabinoid CB1 receptors, British Journal of Pharmacology, 155, 5, 2008. Crossref
-
Shafaroodi Hamed, Ghasemi Mehdi, Dehpour Ahmad R, Elevation of pentylenetetrazole-induced seizure threshold in cholestatic mice: Interaction between opioid and cannabinoid systems, Journal of Gastroenterology and Hepatology, 23, 7pt2, 2008. Crossref
-
Krishtal O., Lozovaya N., Fedorenko A., Savelyev I., Chizhmakov I., The agonists for nociceptors are ubiquitous, but the modulators are specific: P2X receptors in the sensory neurons are modulated by cannabinoids, Pflügers Archiv - European Journal of Physiology, 453, 3, 2006. Crossref
-
Viveros M. P., Llorente R., Moreno E., Marco E. M., Behavioural and neuroendocrine effects of cannabinoids in critical developmental periods, Behavioural Pharmacology, 16, 5-6, 2005. Crossref
-
Colombo Giancarlo, Orrù Alessandro, Lai Paola, Cabras Claudia, Maccioni Paola, Rubio Marina, Gessa Gian Luigi, Carai Mauro A. M., The Cannabinoid CB1 Receptor Antagonist, Rimonabant, as a Promising Pharmacotherapy for Alcohol Dependence: Preclinical Evidence, Molecular Neurobiology, 36, 1, 2007. Crossref
-
Van Laere Koen, In vivo imaging of the endocannabinoid system: a novel window to a central modulatory mechanism in humans, European Journal of Nuclear Medicine and Molecular Imaging, 34, 11, 2007. Crossref
-
Carai Mauro A M, Colombo Giancarlo, Gessa Gian Luigi, Yalamanchili Ratnakumar, Basavarajppa Balapal S, Hungund Basalingappa L, Investigation on the relationship between cannabinoid CB1 and opioid receptors in gastrointestinal motility in mice, British Journal of Pharmacology, 148, 8, 2006. Crossref
-
Cota Daniela, Woods Stephen C, The role of the endocannabinoid system in the regulation of energy homeostasis, Current Opinion in Endocrinology & Diabetes, 12, 5, 2005. Crossref
-
Pinsger Martin, Schimetta Wolfgang, Volc Dieter, Hiermann Erich, Riederer Franz, Pölz Werner, Nutzen einer Add-On-Therapie mit dem synthetischen Cannabinomimetikum Nabilone bei Patienten mit chronischen Schmerzzuständen – eine randomisierte kontrollierte Studie, Wiener klinische Wochenschrift, 118, 11-12, 2006. Crossref
-
Urigüen Leyre, Berrendero Fernando, Ledent Catherine, Maldonado Rafael, Manzanares Jorge, κ- and δ-opioid receptor functional activities are increased in the caudate putamen of cannabinoid CB1receptor knockout mice, European Journal of Neuroscience, 22, 8, 2005. Crossref
-
Hasanein Parisa, Javanmardi Kazem, A potent and selective inhibitor of endocannabinoid uptake, UCM707, potentiates antinociception induced by cholestasis, Fundamental & Clinical Pharmacology, 22, 5, 2008. Crossref
-
Caillé Stéphanie, Parsons Loren H, Cannabinoid Modulation of Opiate Reinforcement through the Ventral Striatopallidal Pathway, Neuropsychopharmacology, 31, 4, 2006. Crossref
-
Massa Federico, Storr Martin, Lutz Beat, The endocannabinoid system in the physiology and pathophysiology of the gastrointestinal tract, Journal of Molecular Medicine, 83, 12, 2005. Crossref
-
Serrano Antonia, Parsons Loren H., Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors, Pharmacology & Therapeutics, 132, 3, 2011. Crossref
-
Husain Shahid, Potter David E., The Opioidergic System: Potential Roles and Therapeutic Indications in the Eye, Journal of Ocular Pharmacology and Therapeutics, 24, 2, 2008. Crossref
-
Spano M. Sabrina, Ellgren Maria, Wang X., Hurd Yasmin L., Prenatal Cannabis Exposure Increases Heroin Seeking with Allostatic Changes in Limbic Enkephalin Systems in Adulthood, Biological Psychiatry, 61, 4, 2007. Crossref
-
Pol Olga, Murtra Patricia, Caracuel Laura, Valverde Olga, Puig Margarita M., Maldonado Rafael, Expression of opioid receptors and c-fos in CB1 knockout mice exposed to neuropathic pain, Neuropharmacology, 50, 1, 2006. Crossref
-
Hasanein Parisa, Shahidi Siamak, Komaki Alireza, Mirazi Naser, Effects of URB597 as an inhibitor of fatty acid amide hydrolase on modulation of nociception in a rat model of cholestasis, European Journal of Pharmacology, 591, 1-3, 2008. Crossref
-
López Hassan H., Webb Sarah A., Nash Sean, Cannabinoid receptor antagonism increases female sexual motivation, Pharmacology Biochemistry and Behavior, 92, 1, 2009. Crossref
-
Hasanein Parisa, The endocannabinoid transport inhibitor AM404 modulates nociception in cholestasis, Neuroscience Letters, 462, 3, 2009. Crossref
-
Jardinaud Fanny, Crété Dominique, Canestrelli Corinne, Ledent Catherine, Roques Bernard P., Noble Florence, CB1 receptor knockout mice show similar behavioral modifications to wild-type mice when enkephalin catabolism is inhibited, Brain Research, 1063, 1, 2005. Crossref
-
Bodnar Richard J., Klein Gad E., Endogenous opiates and behavior: 2004, Peptides, 26, 12, 2005. Crossref
-
Skrabek Ryan Quinlan, Galimova Lena, Ethans Karen, Perry Daryl, Nabilone for the Treatment of Pain in Fibromyalgia, The Journal of Pain, 9, 2, 2008. Crossref
-
Di Marzo Vincenzo, Bisogno Tiziana, De Petrocellis Luciano, Endocannabinoids and Related Compounds: Walking Back and Forth between Plant Natural Products and Animal Physiology, Chemistry & Biology, 14, 7, 2007. Crossref
-
Scavone Jillian L., Mackie Ken, Van Bockstaele Elisabeth J., Characterization of cannabinoid-1 receptors in the locus coeruleus: Relationship with mu-opioid receptors, Brain Research, 1312, 2010. Crossref
-
Hagues Guillaume, Costentin Jean, Duterte-Boucher Dominique, Locomotor effects of morphine or alcohol in mice after a repeated treatment with the cannabinoid agonist HU 210, European Journal of Pharmacology, 586, 1-3, 2008. Crossref
-
Robledo Patricia, Berrendero Fernando, Ozaita Andrés, Maldonado Rafael, Advances in the field of cannabinoid-opioid cross-talk, Addiction Biology, 13, 2, 2008. Crossref
-
Bellocchio Luigi, Vicennati Valentina, Cervino Cristina, Pasquali Renato, Pagotto Uberto, The Endocannabinoid System in the Regulation of Cardiometabolic Risk Factors, The American Journal of Cardiology, 100, 12, 2007. Crossref
-
Nava Felice, Manzato Ezio, Lucchini Alfio, Chronic cannabis use does not affect the normalization of hypothalamic–pituitary–adrenal (HPA) axis induced by methadone in heroin addicts, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 31, 5, 2007. Crossref
-
Femenía Teresa, Manzanares Jorge, Increased ethanol intake in prodynorphin knockout mice is associated to changes in opioid receptor function and dopamine transmission, Addiction Biology, 17, 2, 2012. Crossref
-
Scavone J.L., Sterling R.C., Van Bockstaele E.J., Cannabinoid and opioid interactions: Implications for opiate dependence and withdrawal, Neuroscience, 248, 2013. Crossref
-
Keilhoff Gerburg, Schröder Helmut, Peters Brigitte, Becker Axel, Time-course of neuropathic pain in mice deficient in neuronal or inducible nitric oxide synthase, Neuroscience Research, 77, 4, 2013. Crossref
-
Coria Santiago M., Roura-Martínez David, Ucha Marcos, Assis María Amparo, Miguéns Miguel, García-Lecumberri Carmen, Higuera-Matas Alejandro, Ambrosio Emilio, Strain differences in the expression of endocannabinoid genes and in cannabinoid receptor binding in the brain of Lewis and Fischer 344 rats, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 53, 2014. Crossref
-
Manwell Laurie A., Mallet Paul E., Comparative effects of pulmonary and parenteral Δ9-tetrahydrocannabinol exposure on extinction of opiate-induced conditioned aversion in rats, Psychopharmacology, 232, 9, 2015. Crossref
-
Hazekamp Arno, Fischedick Justin T., Díez Mónica Llano, Lubbe Andrea, Ruhaak Renee L., Chemistry of Cannabis, in Comprehensive Natural Products II, 2010. Crossref
-
Hasanein Parisa, Ghafari-Vahed Masumeh, Fatty acid amide hydrolase inhibitor URB597 prevented tolerance and cognitive deficits induced by chronic morphine administration in rats, Behavioural Pharmacology, 27, 1, 2016. Crossref
-
Jay Gary W., Barkin Robert L., Fibromyalgia, Disease-a-Month, 61, 3, 2015. Crossref
-
Gertsch Jürg, Cannabimimetics, in Novel Therapeutic Agents from Plants, 2009. Crossref
-
Trigo Jose M., Le Foll Bernard, The Role of the Endocannabinoid System in Addiction, in The Endocannabinoid System, 2017. Crossref
-
Sierra Salvador, Gomes Ivone, Devi Lakshmi A., Class A GPCRs: Cannabinoid and Opioid Receptor Heteromers, in G-Protein-Coupled Receptor Dimers, 2017. Crossref
-
Navarrete Francisco, García-Gutiérrez María Salud, Manzanares Jorge, Pharmacological regulation of cannabinoid CB2 receptor modulates the reinforcing and motivational actions of ethanol, Biochemical Pharmacology, 157, 2018. Crossref
-
Navarrete Francisco, Aracil-Fernández Auxiliadora, Manzanares Jorge, Cannabidiol regulates behavioural alterations and gene expression changes induced by spontaneous cannabinoid withdrawal, British Journal of Pharmacology, 175, 13, 2018. Crossref
-
Yoo Hye Bin, DiMuzio Jennifer, Filbey Francesca M., Interaction of Cannabis Use and Aging: From Molecule to Mind, Journal of Dual Diagnosis, 16, 1, 2020. Crossref
-
Horti Andrew G., Raymont Vanessa, Terry Garth E., PET Imaging of Endocannabinoid System, in PET and SPECT of Neurobiological Systems, 2014. Crossref
-
Woods Stephen C., Cota Daniela, Endocannabinoids and Energy Homeostasis, in Treatment of the Obese Patient, 2007. Crossref
-
Fattore Liana, Fadda Paola, Fratta Walter, Endocannabinoid regulation of relapse mechanisms, Pharmacological Research, 56, 5, 2007. Crossref
-
Tarasiuk Aleksandra, Salaga Maciej, Fichna Jakub, Endocannabinoid System, in Encyclopedia of Gastroenterology, 2020. Crossref
-
Solinas Marcello, Yasar Sevil, Goldberg Steven R., Endocannabinoid system involvement in brain reward processes related to drug abuse, Pharmacological Research, 56, 5, 2007. Crossref
-
Gromova O. A., Torshin I. Yu., Putilina M. V., Stakhovskaia L. V., Rudakov K. V., The chemoreactomic analysis of the central mechanisms of action of non-steroidal anti-inflammatory drugs, Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova, 120, 1, 2020. Crossref
-
Di Shi, Malcher-Lopes Renato, Marcheselli Victor L., Bazan Nicolas G., Tasker Jeffrey G., Rapid Glucocorticoid-Mediated Endocannabinoid Release and Opposing Regulation of Glutamate and γ-Aminobutyric Acid Inputs to Hypothalamic Magnocellular Neurons, Endocrinology, 146, 10, 2005. Crossref
-
Ozdemir Ercan, The Role of the Cannabinoid System in Opioid Analgesia and Tolerance, Mini-Reviews in Medicinal Chemistry, 20, 10, 2020. Crossref
-
Gaston Tyler E., Szaflarski Jerzy P., Bowling Allen C., Liu Ying, Seawalt Tristan, Leehey Maureen A., Nelson E. Lee, Rajpal Sharad, Villavicencio Alan T., Bauer Andrew, Burneikiene Sigita, Cannabinoids in Neurologic Conditions, in Cannabis in Medicine, 2020. Crossref
-
Pagotto Uberto, Marsicano Giovanni, Cota Daniela, Lutz Beat, Pasquali Renato, The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance, Endocrine Reviews, 27, 1, 2006. Crossref
-
Mackie Ken, CANNABINOID RECEPTORS AS THERAPEUTIC TARGETS, Annual Review of Pharmacology and Toxicology, 46, 1, 2006. Crossref
-
Hernández-Alvarado R. Bruno, Madariaga-Mazón Abraham, Ortega Alfredo, Martinez-Mayorga Karina, DARK Classics in Chemical Neuroscience: Salvinorin A, ACS Chemical Neuroscience, 11, 23, 2020. Crossref
-
Coffeen U., Canseco‐Alba A., Simón‐Arceo K., Almanza A., Mercado F., León‐Olea M., Pellicer F., Salvinorin A reduces neuropathic nociception in the insular cortex of the rat, European Journal of Pain, 22, 2, 2018. Crossref
-
Terry Garth E., Raymont Vanessa, Horti Andrew G., PET Imaging of the Endocannabinoid System, in PET and SPECT of Neurobiological Systems, 2021. Crossref
-
Takanami Keiko, Sakamoto Hirotaka, Matsuda Ken-Ichi, Hosokawa Koji, Nishi Mayumi, Prossnitz Eric R., Kawata Mitsuhiro, Expression of G protein-coupled receptor 30 in the spinal somatosensory system, Brain Research, 1310, 2010. Crossref
-
Alpár Alán, Di Marzo Vincenzo, Harkany Tibor, At the Tip of an Iceberg: Prenatal Marijuana and Its Possible Relation to Neuropsychiatric Outcome in the Offspring, Biological Psychiatry, 79, 7, 2016. Crossref
-
Nigatu Yeshambel T., Elton‐Marshall Tara, Mann Robert E., Hamilton Hayley A., Associations of cannabis use, opioid use, and their combination with serious psychological distress among Ontario adults, Stress and Health, 38, 1, 2022. Crossref